Benign Prostatic Hyperplasia (BPH) Markets to 2027 - There Have Been 3 Licensing & Asset Acquisition Deals Involving BPH Drugs During 2013-2018

By In The News
June 21, 2019 in The Headlines

Recommended Posts

In The News

Posted June 21, 2019

- Share

Posted June 21, 2019

DUBLIN, June 21, 2019 /PRNewswire/ -- The "Market Spotlight: Benign Prostatic Hyperplasia (BPH)" report has been added to ResearchAndMarkets.com's offering. This Market Spotlight report covers the Benign Prostatic Hyperplasia market, comprising key marketed and pipeline drugs, clinical...

View the full article

Link to comment

Share on other sites

Archived

This topic is now archived and is closed to further replies.

Go to topic listing

Most Contributions
1. In The News
  222255
2. Jaydee
  17884
3. deicer
  13462
4. Kip Powick
  12323
5. dagger
  9614
Tell a friend
Love The Airline Website? Tell a friend!
- Email
- Share
Forum Statistics
- Total Topics
  
  272.7k
- Total Posts
  
  565.6k

Sign In

Benign Prostatic Hyperplasia (BPH) Markets to 2027 - There Have Been 3 Licensing & Asset Acquisition Deals Involving BPH Drugs During 2013-2018

Recommended Posts

In The News

Link to comment

Share on other sites

Archived

Most Contributions

Tell a friend

Forum Statistics

Browse

Activity

Support